Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| HIV Antibodies | 6 | 2019 | 776 | 1.01 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 3 | 2018 | 386 | 1.00 | Why? |
| Viral Envelope Proteins | 3 | 2018 | 3539 | 0.82 | Why? |
| HIV-1 | 7 | 2018 | 3365 | 0.65 | Why? |
| Antibodies, Neutralizing | 18 | 2021 | 25288 | 0.63 | Why? |
| Herpesvirus 4, Human | 1 | 2018 | 387 | 0.56 | Why? |
| Epstein-Barr Virus Infections | 1 | 2018 | 366 | 0.52 | Why? |
| B-Lymphocytes | 7 | 2021 | 4418 | 0.47 | Why? |
| HIV Envelope Protein gp120 | 3 | 2018 | 267 | 0.46 | Why? |
| Antibodies, Monoclonal | 8 | 2021 | 8041 | 0.40 | Why? |
| Membrane Glycoproteins | 1 | 2018 | 2273 | 0.37 | Why? |
| Antibody Affinity | 2 | 2020 | 1078 | 0.27 | Why? |
| Antibodies | 2 | 2021 | 846 | 0.25 | Why? |
| Somatic Hypermutation, Immunoglobulin | 2 | 2020 | 283 | 0.25 | Why? |
| Antibodies, Viral | 9 | 2021 | 51949 | 0.21 | Why? |
| Protein Engineering | 2 | 2021 | 536 | 0.21 | Why? |
| Virus Attachment | 2 | 2018 | 1259 | 0.21 | Why? |
| Precursor Cells, B-Lymphoid | 1 | 2018 | 12 | 0.19 | Why? |
| Germ Cells | 1 | 2018 | 39 | 0.19 | Why? |
| HEK293 Cells | 7 | 2021 | 8394 | 0.18 | Why? |
| Rubella virus | 1 | 2018 | 46 | 0.18 | Why? |
| 3T3 Cells | 1 | 2018 | 152 | 0.18 | Why? |
| HIV Envelope Protein gp160 | 1 | 2017 | 33 | 0.18 | Why? |
| HIV Infections | 4 | 2019 | 11620 | 0.18 | Why? |
| Antibodies, Anti-Idiotypic | 1 | 2017 | 93 | 0.17 | Why? |
| HIV Antigens | 1 | 2018 | 102 | 0.17 | Why? |
| Epitopes, B-Lymphocyte | 3 | 2020 | 1267 | 0.16 | Why? |
| Vaccines | 1 | 2015 | 3692 | 0.16 | Why? |
| Polysaccharides | 3 | 2018 | 854 | 0.15 | Why? |
| Testis | 1 | 2021 | 566 | 0.15 | Why? |
| Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.15 | Why? |
| CHO Cells | 1 | 2018 | 831 | 0.15 | Why? |
| Protein Multimerization | 2 | 2018 | 1336 | 0.15 | Why? |
| Cricetulus | 1 | 2018 | 936 | 0.15 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2017 | 424 | 0.15 | Why? |
| Protein Binding | 7 | 2021 | 11430 | 0.14 | Why? |
| Cryoelectron Microscopy | 2 | 2020 | 2372 | 0.13 | Why? |
| AIDS Vaccines | 1 | 2018 | 452 | 0.13 | Why? |
| Coronaviridae Infections | 1 | 2018 | 442 | 0.13 | Why? |
| Membrane Fusion | 1 | 2018 | 713 | 0.13 | Why? |
| Nanostructures | 1 | 2021 | 700 | 0.13 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2017 | 511 | 0.13 | Why? |
| Immunoglobulin Fc Fragments | 3 | 2021 | 691 | 0.12 | Why? |
| Mice | 7 | 2021 | 21357 | 0.12 | Why? |
| Cell Line | 4 | 2021 | 12040 | 0.11 | Why? |
| Coronaviridae | 1 | 2018 | 923 | 0.11 | Why? |
| CRISPR-Cas Systems | 1 | 2019 | 1397 | 0.10 | Why? |
| Animals | 11 | 2021 | 78931 | 0.10 | Why? |
| Models, Molecular | 5 | 2021 | 7616 | 0.09 | Why? |
| High-Throughput Screening Assays | 1 | 2017 | 1783 | 0.09 | Why? |
| Crystallography, X-Ray | 3 | 2020 | 2689 | 0.08 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.08 | Why? |
| Binding Sites | 4 | 2021 | 6201 | 0.08 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.07 | Why? |
| Glycosylation | 2 | 2018 | 1255 | 0.07 | Why? |
| Immunity, Humoral | 1 | 2019 | 4849 | 0.07 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.07 | Why? |
| Protein Structure, Secondary | 2 | 2018 | 1077 | 0.07 | Why? |
| Brain | 1 | 2021 | 5133 | 0.07 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.07 | Why? |
| Amino Acid Sequence | 3 | 2020 | 6049 | 0.06 | Why? |
| Mice, Transgenic | 2 | 2021 | 2739 | 0.06 | Why? |
| Genes, Synthetic | 1 | 2021 | 39 | 0.06 | Why? |
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2021 | 40 | 0.06 | Why? |
| Receptor, TIE-2 | 1 | 2021 | 42 | 0.06 | Why? |
| Protein Interaction Domains and Motifs | 2 | 2020 | 2134 | 0.06 | Why? |
| Angiopoietins | 1 | 2021 | 45 | 0.06 | Why? |
| CD40 Antigens | 1 | 2021 | 118 | 0.05 | Why? |
| Antibodies, Immobilized | 1 | 2020 | 102 | 0.05 | Why? |
| Betacoronavirus | 6 | 2021 | 204454 | 0.05 | Why? |
| Antibodies, Blocking | 1 | 2020 | 174 | 0.05 | Why? |
| Luciferases | 1 | 2021 | 378 | 0.05 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.05 | Why? |
| INDEL Mutation | 1 | 2019 | 128 | 0.05 | Why? |
| Adoptive Transfer | 1 | 2019 | 250 | 0.04 | Why? |
| Gene Knock-In Techniques | 1 | 2017 | 124 | 0.04 | Why? |
| Carrier Proteins | 1 | 2021 | 513 | 0.04 | Why? |
| Drosophila melanogaster | 1 | 2018 | 85 | 0.04 | Why? |
| Protein Subunits | 1 | 2020 | 755 | 0.04 | Why? |
| Humans | 18 | 2021 | 930598 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2020 | 907 | 0.04 | Why? |
| Recombinant Proteins | 2 | 2018 | 3786 | 0.04 | Why? |
| CD4 Antigens | 1 | 2018 | 306 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| HIV Seropositivity | 1 | 2018 | 320 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2021 | 924 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.04 | Why? |
| Gene Editing | 1 | 2019 | 330 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2018 | 556 | 0.04 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.04 | Why? |
| Sequence Homology, Amino Acid | 1 | 2017 | 945 | 0.04 | Why? |
| Peptidyl-Dipeptidase A | 3 | 2020 | 9659 | 0.03 | Why? |
| Cloning, Molecular | 1 | 2017 | 1036 | 0.03 | Why? |
| Cell Proliferation | 1 | 2021 | 1973 | 0.03 | Why? |
| Receptors, Virus | 2 | 2020 | 5659 | 0.03 | Why? |
| Antibody Specificity | 1 | 2017 | 1328 | 0.03 | Why? |
| Protein Structure, Tertiary | 1 | 2017 | 1565 | 0.03 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Sequence Alignment | 1 | 2017 | 2109 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2018 | 1649 | 0.03 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.03 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.02 | Why? |
| Orthomyxoviridae | 1 | 2017 | 1168 | 0.02 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.02 | Why? |
| Macaca mulatta | 1 | 2018 | 3716 | 0.02 | Why? |
| Swine Diseases | 1 | 2018 | 1219 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Protein Conformation | 1 | 2018 | 4386 | 0.02 | Why? |
| Computer Simulation | 1 | 2021 | 4982 | 0.02 | Why? |
| Coronavirus Infections | 4 | 2021 | 253789 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4545 | 0.02 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.02 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.01 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Female | 3 | 2021 | 380317 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2018 | 21571 | 0.01 | Why? |
| Male | 2 | 2021 | 367725 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Adult | 1 | 2021 | 244371 | 0.00 | Why? |
| Middle Aged | 1 | 2021 | 270681 | 0.00 | Why? |
McGuire's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(137)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_